Aspen Group, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Narrative (Details)

Stockholders' Equity - Narrative (Details)												3 Months Ended				9 Months Ended
Stockholders' Equity - Narrative (Details)	Feb. 26, 2021 USD ($) shares	Oct. 16, 2020 USD ($) shares	Sep. 14, 2020 USD ($) day $ / shares shares	Sep. 02, 2020 $ / shares shares	Aug. 31, 2020 USD ($) $ / shares shares	Jun. 18, 2020	Jun. 08, 2020 USD ($) shares	Jun. 05, 2020 $ / shares	Feb. 04, 2020 USD ($) $ / shares shares	Jan. 22, 2020 USD ($) day $ / shares	Mar. 06, 2019 $ / shares	Jan. 31, 2021 USD ($) $ / shares shares	Oct. 31, 2020 USD ($) shares	Jul. 31, 2020 USD ($) shares	Jan. 31, 2020 USD ($) shares	Jan. 31, 2021 USD ($) $ / shares shares	Jan. 31, 2020 USD ($) shares	Dec. 21, 2020 shares	Dec. 20, 2020 shares	Apr. 30, 2020 USD ($) shares	Dec. 30, 2019 shares	Dec. 13, 2018 shares	Nov. 05, 2018 $ / shares shares	Mar. 13, 2012 shares
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)												1,000,000				1,000,000				1,000,000
Preferred stock issued (in shares)												0				0				0
Preferred stock outstanding (in shares)												0				0				0
Common stock, shares authorized (in shares)												40,000,000				40,000,000				40,000,000
Cashless exercise of stock options (in shares)													36,111
Common stock issued for stock options exercised for cash \| $												$ 363,385			$ 530,668	$ 2,578,700	$ 768,381
Number of shares of common stock surrendered (in shares)																155,486
Common stock issued for vested restricted stock units (in shares)													132,109
Common stock issued for services \| $																$ 19,900	97,748
Common stock issued for stock options exercised for cash (in shares)													502,412
Common stock issued for stock options exercised for cash \| $													$ 945,332	$ 1,269,982
Common stock issued for cashless stock options exercised (in shares)													22,339
Common stock issued for warrants exercised for cash (in shares)														192,049
Common stock issued for warrants exercised for cash \| $														$ 1,081,792		1,081,792
Share price (in dollars per share) \| $ / shares				$ 9.49
Proceeds from warrants exercised \| $																1,081,792	$ 0
Modification charge for warrants exercised \| $														$ 26,000		25,966
Compensation expense \| $												$ 721,067				$ 3,039,729
Treasury stock (in shares)												155,486				155,486				16,667
Treasury stock, value \| $												$ 1,817,414				$ 1,817,414				$ 70,000
Treasury shares cancelled (in shares)		16,667
Retirement of treasury stock \| $		$ 70,000														$ 0
Equity Distribution Agreement
Stockholders Equity [Line Items]
Common stock, capital shares reserved for future issuance, value \| $					$ 12,309,750
Number of shares sold (in shares)																449,632
Sale of stock, gross proceeds (as a percent)					3.00%
Reimbursement expenses \| $					$ 50,000
Total expenses for offering \| $					$ 50,000
Loan Agreements
Stockholders Equity [Line Items]
Warrants granted, exercise price (in dollars per share) \| $ / shares											$ 6.00
Convertible Notes \| Convertible Notes Payable
Stockholders Equity [Line Items]
Average closing price of common stock (in dollars per share) \| $ / shares			$ 10.725							$ 10.725
Consecutive trading day period \| day			20							20
Debt instrument, face amount of loan \| $			$ 10,000,000							$ 5,000,000
Conversion price (in dollars per share) \| $ / shares			$ 7.15							$ 7.15
Amortization expense \| $													$ 1,400,000
Convertible Notes \| Convertible Notes Payable \| Common Stock
Stockholders Equity [Line Items]
Debt conversion, converted instrument, shares issued (in shares)			1,398,602
Revolving Credit Facility \| Credit Facility Agreement
Stockholders Equity [Line Items]
Exercise price of warrants (in dollars per share) \| $ / shares																							$ 5.85
Number of securities called by warrants or rights (in shares)																							92,049
Cooperman Warrants
Stockholders Equity [Line Items]
Decrease in exercise price of common stock purchase warrants								5.00%
Proceeds from warrants exercised \| $							$ 1,081,792
Number of securities called by warrants or rights (in shares)							192,049
Cooperman Warrants \| Loan Agreements
Stockholders Equity [Line Items]
Warrants granted, exercise price (in dollars per share) \| $ / shares								$ 5.70			$ 6.00
Cooperman Warrants \| Revolving Credit Facility \| Credit Facility Agreement
Stockholders Equity [Line Items]
Exercise price of warrants (in dollars per share) \| $ / shares								$ 5.56															$ 5.85
2018 Equity Incentive Plan
Stockholders Equity [Line Items]
Common stock, shares authorized (in shares)																		1,600,000	1,100,000
Number of shares authorized (in shares)																					1,100,000	500,000
Equity Incentive Plan
Stockholders Equity [Line Items]
Number of shares authorized (in shares)																								3,500,000
Common stock, shares remaining for future issuance (in shares)												515,491			286,398	515,491	286,398
Common Stock
Stockholders Equity [Line Items]
Cashless exercise of stock options (in shares)												447,134			121,407	1,364,721	234,233
Common stock issued for stock options exercised for cash \| $												$ 447			$ 121	$ 1,365	$ 234
Common stock issued for vested restricted stock units (in shares)												74,000				206,109
Common stock issued for services (in shares)												2,000				2,000
Common stock issued for stock options exercised for cash (in shares)														415,175
Common stock issued for cashless stock options exercised (in shares)															8,352	22,339	190,559
Common stock issued for warrants exercised for cash (in shares)																192,049
Common stock issued for warrants exercised for cash \| $																$ 192
Share price (in dollars per share) \| $ / shares									$ 9.49
Treasury shares cancelled (in shares)																16,667
Retirement of treasury stock \| $																$ 17
Common Stock \| Former Director
Stockholders Equity [Line Items]
Common stock issued for services (in shares)												2,000
Grant date share price (in dollars per share) \| $ / shares												$ 9.95
Restricted Stock
Stockholders Equity [Line Items]
Unvested shares of restricted common stock outstanding (in shares)												8,224			226,922	8,224	226,922
Total unrecognized compensation expense \| $												$ 38,598			$ 1,285,524	$ 38,598	$ 1,285,524
Weighted average recognition period																1 year
Compensation expense \| $												30,427				$ 51,480
Unrecognized compensation costs \| $												$ 39,000				$ 39,000
Restricted Stock Units (RSUs)
Stockholders Equity [Line Items]
Unvested shares of restricted common stock outstanding (in shares)												669,337			0	669,337	0			643,175
Total unrecognized compensation expense \| $												$ 4,600,000				$ 4,600,000
Restricted shares granted (in shares)									375,000							251,521
Vested (in dollars per share) \| $ / shares																$ 12.46
Stock based compensation expense \| $												175,754
Fair value of RSUs \| $									$ 3,400,000			2,100,000				$ 2,100,000
Vesting period of award (in years)																3 years
Weighted average recognition period						4 years										1 year 9 months 18 days
Derived service period of award									7 months 20 days
Amortization expense \| $												$ 1,200,000
Vested (in shares)												131,250				206,109
Forfeited (in shares)																19,250
Compensation expense \| $												$ 567,239				$ 2,553,717
Unrecognized compensation costs \| $												$ 4,600,000				4,600,000
Restricted Stock Units (RSUs) \| Board of Directors
Stockholders Equity [Line Items]
Restricted shares granted (in shares)												15,791
Vested (in dollars per share) \| $ / shares												$ 11.13
Restricted Stock Units (RSUs) \| Former CFO \| Subsequent Event
Stockholders Equity [Line Items]
Stock based compensation expense \| $	$ 300,000
Vested (in shares)	80,251
Forfeited (in shares)	48,750
Restricted Stock Units (RSUs) \| Share-based Payment Arrangement, Tranche One
Stockholders Equity [Line Items]
Restricted shares granted (in shares)					37,500
Minimum closing price of common stock (in dollars per share) \| $ / shares					$ 9				$ 9
Consecutive trading days					20 days				20 days
Award vesting rights (as a percent)					10.00%				10.00%
Restricted Stock Units (RSUs) \| Share-based Payment Arrangement, Tranche Two
Stockholders Equity [Line Items]
Restricted shares granted (in shares)				93,750
Minimum closing price of common stock (in dollars per share) \| $ / shares				$ 10					$ 10
Consecutive trading days				20 days					20 days
Award vesting rights (as a percent)				25.00%					25.00%
Restricted Stock Units (RSUs) \| Share-based Payment Arrangement, Tranche Three
Stockholders Equity [Line Items]
Total unrecognized compensation expense \| $												$ 1,700,000				$ 1,700,000
Restricted shares granted (in shares)									243,750
Minimum closing price of common stock (in dollars per share) \| $ / shares									$ 12
Consecutive trading days									20 days
Restricted Stock Units (RSUs) \| Minimum
Stockholders Equity [Line Items]
Grant price of award (in dollars per share) \| $ / shares																$ 6.95
Restricted Stock Units (RSUs) \| Maximum
Stockholders Equity [Line Items]
Grant price of award (in dollars per share) \| $ / shares																$ 12.78
Stock Incentive Plan and Stock Option Grants to Employees and Directors
Stockholders Equity [Line Items]
Cashless exercise of stock options (in shares)																1,400,832
Options granted (in shares)												0				0
Stock options
Stockholders Equity [Line Items]
Weighted average recognition period																1 year 1 month 6 days
Compensation expense \| $												$ 123,401				$ 434,532
Unrecognized compensation costs \| $												$ 275,000				$ 275,000